Literature DB >> 21723365

Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.

J A Bjork1, J L Butenhoff, K B Wallace.   

Abstract

Perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) are surface active fluorochemicals that, due to their exceptional stability to degradation, are persistent in the environment. Both PFOA and PFOS are eliminated slowly in humans, with geometric mean serum elimination half-lives estimated at 3.5 and 4.8 years, respectively. The biological activity of PFOA and PFOS in rodents is attributed primarily to transactivation of the nuclear receptor peroxisome proliferator activated receptor alpha (PPARA), which is an important regulator of lipid and carbohydrate metabolism. However, there are significant species-specific differences in the response to PFOA and PFOS exposure; non-rodent species, including humans, are refractory to several but not all of these effects. Many of the metabolic effects have been attributed to the activation of PPARA; however, recent studies using PPARα knockout mice demonstrate residual PPARA-independent effects, some of which may involve the activation of alternate nuclear receptors, including NR1I2 (PXR), NR1I3 (CAR), NR1H3 (LXRA), and NR1H4 (FXR). The objective of this investigation was to characterize the activation of multiple nuclear receptors and modulation of metabolic pathways associated with exposure to PFOA and PFOS, and to compare and contrast the effects between rat and human primary liver cells using quantitative reverse transcription PCR (RT-qPCR). Our results demonstrate that multiple nuclear receptors participate in the metabolic response to PFOA and PFOS exposure resulting in a substantial shift from carbohydrate metabolism to fatty acid oxidation and hepatic triglyceride accumulation in rat liver cells. This shift in intermediary metabolism was more pronounced for PFOA than PFOS. Furthermore, while there is some similarity in the activation of metabolic pathways between rat and humans, particularly in PPARA regulated responses; the changes in primary human cells were more subtle and possibly reflect an adaptive metabolic response rather than an overt metabolic regulation observed in rodents.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723365     DOI: 10.1016/j.tox.2011.06.012

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  52 in total

1.  Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.

Authors:  Kaberi P Das; Carmen R Wood; Mimi T Lin; Anatoly A Starkov; Christopher Lau; Kendall B Wallace; J Christopher Corton; Barbara D Abbott
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

2.  Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.

Authors:  Lobna M Eldasher; Xia Wen; Michael S Little; Kristin M Bircsak; Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicology       Date:  2013-02-19       Impact factor: 4.221

3.  Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in mice.

Authors:  Limin Zhang; Bipin Rimal; Robert G Nichols; Yuan Tian; Philip B Smith; Emmanuel Hatzakis; Shu-Ching Chang; John L Butenhoff; Jeffrey M Peters; Andrew D Patterson
Journal:  Toxicology       Date:  2020-01-08       Impact factor: 4.221

Review 4.  Role of xenobiotics in the induction and progression of fatty liver disease.

Authors:  James E Klaunig; Xilin Li; Zemin Wang
Journal:  Toxicol Res (Camb)       Date:  2018-05-18       Impact factor: 3.524

5.  Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.

Authors:  Andres Cardenas; Marie-France Hivert; Diane R Gold; Russ Hauser; Ken P Kleinman; Pi-I D Lin; Abby F Fleisch; Antonia M Calafat; Xiaoyun Ye; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Diabetes Care       Date:  2019-07-11       Impact factor: 19.112

6.  Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet-Induced Hepatic Steatosis in Mice.

Authors:  Ian Huck; Kevin Beggs; Udayan Apte
Journal:  Int J Toxicol       Date:  2018-08-22       Impact factor: 2.032

7.  Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-19       Impact factor: 4.219

8.  Effects of perfluorooctanesulfonate and perfluorobutanesulfonate on the growth and sexual development of Xenopus laevis.

Authors:  Qin-Qin Lou; Yin-Feng Zhang; Zhen Zhou; Ya-Li Shi; Ya-Nan Ge; Dong-Kai Ren; Hai-Ming Xu; Ya-Xian Zhao; Wu-Ji Wei; Zhan-Fen Qin
Journal:  Ecotoxicology       Date:  2013-08-02       Impact factor: 2.823

9.  Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines.

Authors:  John Bassler; Alan Ducatman; Meenal Elliott; Sijin Wen; Banrida Wahlang; John Barnett; Matthew C Cave
Journal:  Environ Pollut       Date:  2019-01-18       Impact factor: 8.071

10.  PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.

Authors:  Mitchell B Rosen; Kaberi P Das; John Rooney; Barbara Abbott; Christopher Lau; J Christopher Corton
Journal:  Toxicology       Date:  2017-05-27       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.